National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 19598 [2024-05727]
Download as PDF
<![CDATA[
19598
Federal Register / Vol. 89, No. 54 / Tuesday, March 19, 2024 / Notices
adoption and implementation of
transaction standards, unique
identifiers, code sets, and operating
rules adopted under the Patient
Protection and Affordable Care Act
(ACA).2
The meeting agenda will include
discussion of the 2024 workplan
including the NCVHS Report to
Congress, and briefings and discussions
with invited experts on several health
data policy topics, including: standards
for SDOH data elements; possible
implications of Value Based Care
Models vs Fee-For-Service on HIPAA
standards; an overview of the key
elements of the Trusted Exchange
Framework and Common Agreement
(TEFCA) published by the Office of the
National Coordinator for Health IT
(ONC) in November 2023; and
exploration of privacy and security in
AI in technology and healthcare.
The NCVHS Workgroup on Timely
and Strategic Action to Inform ICD–11
Policy for morbidity will report to the
full Committee on Phase II of its work
focusing on analysis of the recent
Request for Information (RFI), published
in October 2023.3
The Committee will reserve time on
the agenda for public comment. Meeting
times and topics are subject to change.
Please refer to the agenda posted on the
NCVHS website for updates: https://
ncvhs.hhs.gov/meetings/full-committeemeeting-16/.
Sharon Arnold,
Associate Deputy Assistant Secretary, Office
of Science and Data Policy, Office of the
Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2024–05779 Filed 3–18–24; 8:45 am]
BILLING CODE 4150–05–P
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
2 Public Law 111–148, 124 Stat.119, available at
https://www.congress.gov/111/plaws/publ148/
PLAW-111publ148.pdf.
3 Federal Register Notice, October 16, 2023:
https://www.federalregister.gov/documents/2023/
10/16/2023-22753/national-committee-on-vitaland-health-statistics.
17:41 Mar 18, 2024
Jkt 262001
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; P01 and R03 Review.
Date: April 3, 2024.
Time: 10:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: M. Catherine Bennett,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, NINDS/NIH/HHS, NSC, 6001
Executive Blvd., Rockville, MD 20852, 301–
435–1766, bennettc3@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: March 13, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–05727 Filed 3–18–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer at (240) 276–
1243.
Comments are invited on: (a) whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Project: Minority AIDS Initiative—
Management Reporting Tools (MAI–
MRTs)—(OMB No. 0930–0357)—
Renewal
The Substance Abuse and Mental
Health Services Administration
(SAMHSA), Center for Substance Abuse
Prevention (CSAP) is requesting from
the Office of Management and Budget
(OMB) approval for the renewal of
Minority AIDS Initiative (MAI)
monitoring tools, which includes both
youth and adult questionnaires, as well
as the quarterly progress report. This
revision includes the inclusion of new
cohorts, substantial revisions to the
youth and adult questionnaires, updates
to the data used to estimate response
rates and expected numbers of
participants by service duration (see
Table 1 below).
The cohorts of grantees funded by the
MAI and included in this clearance
request are:
• Prevention Navigators 2019
• Prevention Navigators 2020
• Prevention Navigators 2021
• Prevention Navigators 2022
• Prevention Navigators 2023
The target population for the grantees
will be at-risk minority adolescents and
young adults. All MAI grantees are
expected to report their monitoring data
using SAMHSA’s Strategic Prevention
Framework (SPF) and to target minority
populations, as well as other high-risk
groups residing in communities of color
with high prevalence of Substance
Abuse and HIV/AIDS. The primary
objectives of the monitoring tools
include:
• Assess the success of the MAI in
reducing risk factors and increasing
protective factors associated with the
transmission of the Human
Immunodeficiency Virus (HIV),
Hepatitis C Virus (HCV) and other
sexually transmitted diseases (STD).
• Measure the effectiveness of
evidence-based programs and
infrastructure development activities
such as: outreach and training,
mobilization of key stakeholders,
substance abuse and HIV/AIDS
counseling and education, testing,
referrals to appropriate medical
treatment and/or other intervention
strategies (i.e., cultural enrichment
E:\FR\FM\19MRN1.SGM
19MRN1
]]>Agencies
[Federal Register Volume 89, Number 54 (Tuesday, March 19, 2024)]
[Notices]
[Page 19598]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05727]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; P01 and R03 Review.
Date: April 3, 2024.
Time: 10:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852.
Contact Person: M. Catherine Bennett, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH/HHS, NSC, 6001 Executive Blvd., Rockville, MD
20852, 301-435-1766, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS).
Dated: March 13, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-05727 Filed 3-18-24; 8:45 am]
BILLING CODE 4140-01-P
